SCHEMBL9611754

SCHEMBL9611754

C=CC1=C(c2cc3ccc4ccccc4c3c3ccccc23)CCC(c2nc3ccccc3n2C)=C1C=C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 12/20 0.39
RAB9A P51151 9/20 0.39
NPC1 O15118 9/20 0.39
MEN1 O00255 7/20 0.36
KMT2A Q03164 7/20 0.36
ALDH1A1 P00352 13/20 0.35
HPGD P15428 8/20 0.35
HSD17B10 Q99714 7/20 0.35
LMNA P02545 3/20 0.35
POLB P06746 3/20 0.35
TSHR P16473 3/20 0.35
ALOX15 P16050 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ALOX12 P18054 1/20 0.35
MPI P34949 1/20 0.35
PDGFRB P09619 1/20 0.35
FGFR1 P11362 1/20 0.35
MAPT P10636 7/20 0.35
SMN1; SMN2 Q16637 7/20 0.35
GAA P10253 5/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9976897 0.81 KDM4E (0.53) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL9976889 0.77 KDM4E (0.50) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL9976879 0.76 ALDH1A1 (0.55) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL9611736 0.74 MEN1 (0.47) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL17692034 0.74 KDM4E (0.44) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL9976887 0.74 KDM4E (0.49) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL15942646 0.68 ALDH1A1 (0.60) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL9611745 0.68 PDE10A (0.47) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL9611818 0.67 KDM4E (0.41) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL16692191 0.67 KDM4E (0.64) KDM4ERAB9ANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120132899-A1 NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-05-31 US disclosed
US-20120132899-A1 NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120132899-A1 NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME H1-2, L1CAM, H1-0 KDM4E 2763/4885RAB9A 1663/4885NPC1 1609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.